Literature DB >> 15240655

Understanding the pro- and anti-inflammatory properties of IL-27.

Alejandro V Villarino1, Elaine Huang, Christopher A Hunter.   

Abstract

The recent identification of IL-27 (IL-27p28/EBV-induced gene 3) and IL-27R (WSX-1/gp130) has provided new insights for the biology of IL-6/IL-12 family cytokines. Initial studies indicated that IL-27 can directly regulate T cell functions and suggested an important role for it in promoting Th1 type responses. However, subsequent studies have revealed that IL-27R signaling influences a variety of immune cell types and can inhibit either Th1 or Th2 type responses. Though elucidation of the Jak/STAT signaling pathways activated by IL-27R ligation has unveiled some of the molecular mechanisms used by IL-27 to promote inflammation, little is known about the anti-inflammatory activities of this cytokine. Thus, the aim of this review is to discuss the pleotropic nature of the IL-27/IL-27R interaction and attempt to reconcile the pro- and anti-inflammatory properties of this immunomodulator.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240655     DOI: 10.4049/jimmunol.173.2.715

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  88 in total

1.  Mutations in the transmembrane and juxtamembrane domains enhance IL27R transforming activity.

Authors:  Que T Lambert; Anuradha Pradhan; J Devon Roll; Gary W Reuther
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

Review 2.  IL-17 and Th17 cells in tuberculosis.

Authors:  Egídio Torrado; Andrea M Cooper
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

3.  Induction of Interleukin 10 by Borrelia burgdorferi Is Regulated by the Action of CD14-Dependent p38 Mitogen-Activated Protein Kinase and cAMP-Mediated Chromatin Remodeling.

Authors:  Bikash Sahay; Kathleen Bashant; Nicole L J Nelson; Rebeca L Patsey; Shiva Kumar Gadila; Rebecca Boohaker; Ashutosh Verma; Klemen Strle; Timothy J Sellati
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

4.  Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27.

Authors:  George D Kalliolias; Rachael A Gordon; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

5.  Genome-wide profiling of in vivo LPS-responsive genes in splenic myeloid cells.

Authors:  Myeong Sup Lee; Byungil Kim; Sun-Min Lee; Woo-Cheul Cho; Wook-Bin Lee; Ji-Seon Kang; Un Yung Choi; Jaemyun Lyu; Young-Joon Kim
Journal:  Mol Cells       Date:  2013-05-10       Impact factor: 5.034

Review 6.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

Review 7.  A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes.

Authors:  Noriko Morishima; Izuru Mizoguchi; Masae Okumura; Yukino Chiba; Mingli Xu; Motomu Shimizu; Masanori Matsui; Junichiro Mizuguchi; Takayuki Yoshimoto
Journal:  J Biomed Biotechnol       Date:  2010-04-29

8.  Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A.

Authors:  Gregory F Sonnenberg; Meera G Nair; Thomas J Kirn; Colby Zaph; Lynette A Fouser; David Artis
Journal:  J Exp Med       Date:  2010-05-24       Impact factor: 14.307

9.  Associations between polymorphisms in IL-12A, IL-12B, IL-12Rβ1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer.

Authors:  Yi-Peng Tao; Wan-Ling Wang; Song-Yue Li; Jian Zhang; Qi-Zhong Shi; Fen Zhao; Bao-Sheng Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-28       Impact factor: 4.553

10.  Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130.

Authors:  Yuichi Hashimoto; Megumi Kurita; Sadakazu Aiso; Ikuo Nishimoto; Masaaki Matsuoka
Journal:  Mol Biol Cell       Date:  2009-04-22       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.